{"id":5471,"date":"2020-07-18T08:55:00","date_gmt":"2020-07-18T08:55:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5471"},"modified":"2024-05-02T10:29:04","modified_gmt":"2024-05-02T08:29:04","slug":"factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/","title":{"rendered":"Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ishiguro+Y&amp;cauthor_id=33029920\">Yoh Ishiguro<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33029920\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ohmori+T&amp;cauthor_id=33029920\">Toshihide Ohmori<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33029920\/#affiliation-2\">2<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Umemura+K&amp;cauthor_id=33029920\">Ken Umemura<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33029920\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Iizuka+M&amp;cauthor_id=33029920\">Masahiro Iizuka<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33029920\/#affiliation-4\">4<\/a><\/sup> ,Ther Apher Dial 2020 Oct 7.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>GMA was an effective treatment for corticosteroid-na\u00efve patients and the efficacy sustained longer in those not receiving immunomodulators during GMA. GMA fulfills the notion that apheresis is to induce disease remission by removing from the body factors known to perpetuate disease. In therapeutic settings, these findings should help better decision making and avoid futile use of medical resources.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33029920\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33029920\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Yoh Ishiguro&nbsp;1,&nbsp;Toshihide Ohmori&nbsp;2,&nbsp;Ken Umemura&nbsp;3,&nbsp;Masahiro Iizuka&nbsp;4 ,Ther Apher Dial 2020 Oct 7. GMA was an effective treatment for corticosteroid-na\u00efve patients and the efficacy sustained longer in those not receiving immunomodulators during GMA. GMA fulfills the notion that apheresis is to induce disease remission by removing from the body factors known to perpetuate disease. In therapeutic settings, [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[147,330,346,62,321,326,148,100,185,306],"class_list":["post-5471","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-clinical-trial","scientific_tags-cohort","scientific_tags-corticosteroid-naive","scientific_tags-gastroenterology","scientific_tags-immunomodulators","scientific_tags-long-term-efficacy","scientific_tags-multicenter","scientific_tags-steroid-naive","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Yoh Ishiguro&nbsp;1,&nbsp;Toshihide Ohmori&nbsp;2,&nbsp;Ken Umemura&nbsp;3,&nbsp;Masahiro Iizuka&nbsp;4 ,Ther Apher Dial 2020 Oct 7. GMA was an effective treatment for corticosteroid-na\u00efve patients and the efficacy sustained longer in those not receiving immunomodulators during GMA. GMA fulfills the notion that apheresis is to induce disease remission by removing from the body factors known to perpetuate disease. In therapeutic settings, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T08:29:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/\",\"name\":\"Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2020-07-18T08:55:00+00:00\",\"dateModified\":\"2024-05-02T08:29:04+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/","og_locale":"es_ES","og_type":"article","og_title":"Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study - Adacyte","og_description":"Yoh Ishiguro&nbsp;1,&nbsp;Toshihide Ohmori&nbsp;2,&nbsp;Ken Umemura&nbsp;3,&nbsp;Masahiro Iizuka&nbsp;4 ,Ther Apher Dial 2020 Oct 7. GMA was an effective treatment for corticosteroid-na\u00efve patients and the efficacy sustained longer in those not receiving immunomodulators during GMA. GMA fulfills the notion that apheresis is to induce disease remission by removing from the body factors known to perpetuate disease. In therapeutic settings, [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T08:29:04+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/","name":"Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2020-07-18T08:55:00+00:00","dateModified":"2024-05-02T08:29:04+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/factors-associated-with-the-outcomes-in-ulcerative-colitis-patients-undergoing-granulocyte-and-monocyte-adsorptive-apheresis-as-remission-induction-therapy-a-multicenter-cohort-study\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5471"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}